Linezolid-Associated Acute Interstitial Nephritis and Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome

被引:29
|
作者
Savard, Sebastien
Desmeules, Simon
Riopel, Julie [2 ]
Agharazii, Mohsen [1 ]
机构
[1] CHUQ, Ctr Rech, Hotel Dieu Quebec, Hotel Dieu Quebec Hosp,Div Nephrol, Quebec City, PQ G1R 2J6, Canada
[2] CHUQ, Div Pathol, Hotel Dieu Quebec Hosp, Quebec City, PQ G1R 2J6, Canada
关键词
Linezolid; acute kidney injury; acute interstitial nephritis; drug rash with eosinophilia and systemic symptoms (DRESS) syndrome; eosinophilia; hepatitis; fever; RESISTANT STAPHYLOCOCCUS-AUREUS; VANCOMYCIN; INFECTIONS; FAILURE; PATIENT;
D O I
10.1053/j.ajkd.2009.07.013
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Linezolid is a recent addition to the antibiotic armamentarium against Gram-positive bacteria, including multiresistant staphylococci and enterococci. Linezolid is relatively well tolerated and is not believed to be nephrotoxic. However, we report the case of an 88-year-old woman who was treated for prosthetic joint infection and methicillin-resistant Staphylococcus aureus bacteremia with vancomycin followed by linezolid therapy. On day 7 of linezolid treatment, the patient developed severe pruritus, macular rash, facial edema, eosinophilia, marked increase in serum creatinine level, and mild hepatitis. Renal biopsy showed acute interstitial nephritis with eosinophilic cells. Discontinuation of linezolid and a short course of prednisone led to rapid improvement of renal function. This case of linezolid-associated acute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in a patient treated with linezolid raises concerns about the presumed renal safety of this drug. Clinicians should be aware of this potential life-threatening adverse reaction and monitor kidney function while patients are using linezolid. Am J Kidney Dis 54:e17-e20. (C) 2009 by the National Kidney Foundation, Inc.
引用
收藏
页码:E17 / E20
页数:4
相关论文
共 50 条
  • [1] Drug Rash With Eosinophilia and Systemic Symptoms (DRESS Syndrome)
    Gordon, Justin S.
    Neyman, Kimberly M.
    Wells, Ryan D.
    Chen, Suephy C.
    CUTIS, 2012, 89 (04): : 180 - 182
  • [2] DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS Syndrome)
    Lobo, Ines
    Ferreira, Marcia
    Velho, Gloria
    Sanches, Madalena
    Selores, Manuela
    ACTA MEDICA PORTUGUESA, 2008, 21 (04): : 367 - 372
  • [3] Drug rash with eosinophilia and systemic symptoms (dress syndrome)
    Tas, S
    Simonart, T
    ACTA CLINICA BELGICA, 1999, 54 (04) : 197 - 200
  • [4] Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Associated with Rifampicin
    Ataxca Gonzalez, M. A.
    Gonzalez, J. E.
    Rendon, A.
    Rivera, C. P.
    Mercado Logoria, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [5] DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) SYNDROME
    Kodela, Jennifer
    Lakshmanan, Srividhya
    Keyhanian, Kiandokht
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S506 - S507
  • [6] DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) syndrome associated with nevirapine therapy
    Bourezane, Y
    Salard, D
    Hoen, B
    Vandel, S
    Drobacheff, C
    Laurent, R
    CLINICAL INFECTIOUS DISEASES, 1998, 27 (05) : 1321 - 1322
  • [7] Drug hypersensitivity syndrome: drug rash with eosinophilia and systemic symptoms (DRESS)
    Vaillant, L
    JOURNAL OF DERMATOLOGICAL TREATMENT, 1999, 10 (04) : 267 - 272
  • [8] DRESS (Drug Rash with Eosinophilia and Systemic Symptoms)
    Pichler, C. E.
    Pichler, W. J.
    ALLERGOLOGIE, 2009, 32 (09) : 365 - 370
  • [9] Linezolid-Associated Interstitial Nephritis
    Suresh, Varsha V.
    Sanchez, Mario A. Mendoza
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 144 - 144
  • [10] A case of DRESS (drug reaction with eosinophilia and systemic symptoms) with acute interstitial nephritis secondary to lenalidomide
    Shaaban, Hamid
    Layne, Trevor
    Guron, Gunwant
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (04) : 302 - 304